Le Lézard
Classified in: Health, Covid-19 virus

CVS Health Announces Availability of Moderna Booster to Eligible Populations

WOONSOCKET, R.I., Oct. 22, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that, following authorization from the Centers for Disease Control and Prevention (CDC) based on guidance from the organization's Advisory Committee on Immunization Practices (ACIP), select CVS Pharmacy locations are now offering the Moderna COVID-19 booster shot to eligible populations beginning Friday, October 22, in addition to the previously authorized Pfizer-BioNTech COVID-19 booster.

Following are the guidelines set by ACIP and CDC for the Moderna and Pfizer-BioNTech booster shot:

The CDC also recommends a booster shot for that patients who received the Johnson & Johnson (Janssen) COVID-19 vaccine and are 18 and older were vaccinated two or more months ago. Based on new guidance provided by the CDC, eligible patients may choose which vaccine they receive as a booster dose. Some people may have a preference for the vaccine type that they originally received, and others may prefer to get a different booster. The CDC's recommendations now allow for this type of mix and match dosing for booster shots. For medical guidance around vaccines and boosters please contact your healthcare provider or visit www.vaccine.gov.

Patients interested in receiving a COVID-19 booster or their initial vaccine series are strongly encouraged to make an appointment at CVS.com or the CVS App to secure a convenient time and location. Patients may also conveniently schedule a flu vaccine at the same time as their COVID-19 vaccine when scheduling on-line. CDC guidance allows for administration of any of the currently authorized COVID-19 vaccines at the same time as the flu vaccine. 

"The systems we've built and our deep experience in providing vaccinations allows us to play a leading role in administering booster shots to eligible populations," said Troyen A. Brennan, M.D., MPH, Executive Vice President and Chief Medical Officer of CVS Health. "We also remain focused on providing easy and convenient opportunities for the unvaccinated to receive their first doses."

When scheduling an appointment on CVS.com, patients will be asked to provide the manufacturer and date of their last COVID-19 vaccine and will be able to schedule an appointment for a Moderna or Pfizer-BioNTech booster dose if they have had two previous doses with the same vaccine at least six months prior, or one dose of the Johnson & Johnson (Janssen) vaccine at least two months prior. Per guidance from the CDC, patients will be asked to self-attest to their eligibility as defined by the eligibility guidelines, to help reduce barriers to access for these select populations.

With the authorization of the Moderna COVID-19 booster dose, more than 9,800 CVS Pharmacy locations are now able to offer COVID-19 booster shots to eligible populations. Each participating CVS Pharmacy location is offering either the Pfizer-BioNTech or Moderna vaccine.

CVS Health has administered more than 34 million COVID-19 vaccines and 32 million COVID-19 tests across the country to date. The company has played a prominent role in administering third doses to the immunocompromised and previously authorized booster shots from other manufacturers and is prepared to expand vaccine eligibility to ages 5-11 as soon as authorized to do so by public health agencies.

About CVS Health
CVS Health is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and our nearly 300,000 dedicated colleagues ? including more than 40,000 physicians, pharmacists, nurses, and nurse practitioners. Wherever and whenever people need us, we help them with their health ? whether that's managing chronic diseases, staying compliant with their medications, or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system ? and their personal health care ? by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Learn more at www.cvshealth.com.

Media contact
Matthew Blanchette



These press releases may also interest you

at 21:05
Monument Mining Limited "Monument" or the "Company" today announced its first quarter of fiscal 2022 production and financial results for the three months ended September 30, 2021. All amounts are expressed in United States dollars ("US$") unless...

at 21:00
The "In-vitro Diagnostics Market - Competitive Analysis, Drivers, Challenges, and  Five Force Analysis" report has been added to Technavio's offering. The In-vitro diagnostics market is set to grow by USD 35.77 billion, progressing at a CAGR of 7.95%...

at 20:34
SIR Royalty Income Fund (the "Fund") today announced that SIR Corp. ("SIR" or the "Company"), the operating entity from which the Fund earns equity income, has filed its financial results for the 16-week and 52-week periods ended August 29, 2021...

at 20:30
Hologic, Inc. announced today that its three SARS-CoV-2 tests all detect the recently emerged Omicron variant of the coronavirus that causes COVID-19. Initially identified in South Africa and subsequently in a number of African, European and North...

at 20:30
The emulsion adhesives market is set to grow by USD 4.64 bn, progressing at a CAGR of  5.79% from 2020 to 2025. The market is fragmented, and the degree of fragmentation will accelerate during the forecast period....

at 20:18
1933 Industries Inc. (the "Company" or "1933 Industries") , a Nevada-focused cannabis consumer packaged goods company, is pleased to announce its fourth quarter ("Q4 2021") and audited annual financial results for the...

News published on 22 october 2021 at 12:13 and distributed by: